447 related articles for article (PubMed ID: 32907830)
1. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
[TBL] [Abstract][Full Text] [Related]
2. Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage.
Perugorria MJ; Esparza-Baquer A; Oakley F; Labiano I; Korosec A; Jais A; Mann J; Tiniakos D; Santos-Laso A; Arbelaiz A; Gawish R; Sampedro A; Fontanellas A; Hijona E; Jimenez-Agüero R; Esterbauer H; Stoiber D; Bujanda L; Banales JM; Knapp S; Sharif O; Mann DA
Gut; 2019 Mar; 68(3):533-546. PubMed ID: 29374630
[TBL] [Abstract][Full Text] [Related]
3. Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma.
Liao R; Sun TW; Yi Y; Wu H; Li YW; Wang JX; Zhou J; Shi YH; Cheng YF; Qiu SJ; Fan J
Cancer Sci; 2012 Jun; 103(6):984-92. PubMed ID: 22417086
[TBL] [Abstract][Full Text] [Related]
4. Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.
Lai KKY; Kweon SM; Chi F; Hwang E; Kabe Y; Higashiyama R; Qin L; Yan R; Wu RP; Lai K; Fujii N; French S; Xu J; Wang JY; Murali R; Mishra L; Lee JS; Ntambi JM; Tsukamoto H
Gastroenterology; 2017 May; 152(6):1477-1491. PubMed ID: 28143772
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of triggering receptors expressed on myeloid cells-1 with the oncogenesis and progression of hepatocellular carcinoma].
Li W; Zhang N; Ou Y; Zhou Z; Zhao F; Wu Q; Yang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1705-9, 1720. PubMed ID: 26714901
[TBL] [Abstract][Full Text] [Related]
6. Mice With Increased Numbers of Polyploid Hepatocytes Maintain Regenerative Capacity But Develop Fewer Hepatocellular Carcinomas Following Chronic Liver Injury.
Lin YH; Zhang S; Zhu M; Lu T; Chen K; Wen Z; Wang S; Xiao G; Luo D; Jia Y; Li L; MacConmara M; Hoshida Y; Singal AG; Yopp A; Wang T; Zhu H
Gastroenterology; 2020 May; 158(6):1698-1712.e14. PubMed ID: 31972235
[TBL] [Abstract][Full Text] [Related]
7. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
[TBL] [Abstract][Full Text] [Related]
8. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
9. TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.
Duan M; Wang ZC; Wang XY; Shi JY; Yang LX; Ding ZB; Gao Q; Zhou J; Fan J
Ann Surg Oncol; 2015 Sep; 22(9):3121-9. PubMed ID: 25465376
[TBL] [Abstract][Full Text] [Related]
10. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
[TBL] [Abstract][Full Text] [Related]
11. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.
Wu Q; Chen JX; Chen Y; Cai LL; Wang XZ; Guo WH; Zheng JF
Cell Death Dis; 2018 Feb; 9(2):232. PubMed ID: 29445190
[TBL] [Abstract][Full Text] [Related]
12. Role of insulin receptor substrates in the progression of hepatocellular carcinoma.
Sakurai Y; Kubota N; Takamoto I; Obata A; Iwamoto M; Hayashi T; Aihara M; Kubota T; Nishihara H; Kadowaki T
Sci Rep; 2017 Jul; 7(1):5387. PubMed ID: 28710407
[TBL] [Abstract][Full Text] [Related]
13. Periostin deficiency reduces diethylnitrosamine-induced liver cancer in mice by decreasing hepatic stellate cell activation and cancer cell proliferation.
Xiao H; Zhang Y; Li Z; Liu B; Cui D; Liu F; Chen D; Liu Y; Ouyang G
J Pathol; 2021 Oct; 255(2):212-223. PubMed ID: 34228359
[TBL] [Abstract][Full Text] [Related]
14. Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration.
Nozaki Y; Hikita H; Tanaka S; Fukumoto K; Urabe M; Sato K; Myojin Y; Doi A; Murai K; Sakane S; Saito Y; Kodama T; Sakamori R; Tatsumi T; Takehara T
Sci Rep; 2021 Feb; 11(1):3363. PubMed ID: 33564095
[TBL] [Abstract][Full Text] [Related]
15. Cell expression patterns of CD147 in N-diethylnitrosamine/phenobarbital-induced mouse hepatocellular carcinoma.
Lu M; Wu J; He F; Wang XL; Li C; Chen ZN; Bian H
J Mol Histol; 2015 Feb; 46(1):79-91. PubMed ID: 25447507
[TBL] [Abstract][Full Text] [Related]
16. Haematopoietic cell-derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury.
Cubero FJ; Zhao G; Nevzorova YA; Hatting M; Al Masaoudi M; Verdier J; Peng J; Schaefer FM; Hermanns N; Boekschoten MV; Grouls C; Gassler N; Kiessling F; Muller M; Davis RJ; Liedtke C; Trautwein C
J Hepatol; 2015 Jan; 62(1):140-9. PubMed ID: 25173965
[TBL] [Abstract][Full Text] [Related]
17. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.
Wright JH; Johnson MM; Shimizu-Albergine M; Bauer RL; Hayes BJ; Surapisitchat J; Hudkins KL; Riehle KJ; Johnson SC; Yeh MM; Bammler TK; Beyer RP; Gilbertson DG; Alpers CE; Fausto N; Campbell JS
Int J Cancer; 2014 Feb; 134(4):778-88. PubMed ID: 23929039
[TBL] [Abstract][Full Text] [Related]
18. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
19. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
20. Expression of the type 3 InsP
Guerra MT; Florentino RM; Franca A; Lima Filho AC; Dos Santos ML; Fonseca RC; Lemos FO; Fonseca MC; Kruglov E; Mennone A; Njei B; Gibson J; Guan F; Cheng YC; Ananthanarayanan M; Gu J; Jiang J; Zhao H; Lima CX; Vidigal PT; Oliveira AG; Nathanson MH; Leite MF
Gut; 2019 Sep; 68(9):1676-1687. PubMed ID: 31315892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
